US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.73

+1.431.47%

Pre-market: 98.72-0.0120-0.01%07:02 EDT

Volume:7K

Turnover:644.33K

Market Cap:406.77M

PE:55.06

High:98.82

Open:97.68

Low:97.68

Close:97.30

52wk High:98.82

52wk Low:67.56

Shares:4.12M

Float Shares:4.12M

Volume Ratio:0.28

T/O Rate:0.16%

Dividend:1.55

Dividend Rate:1.57%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.64

PE(LYR):5.29

Loading ...

Overview Company News Filings

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live

Amgen Extends Obesity Trial, Sharpening Its Long-Term Weight-Loss Bet

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485

THOMSON REUTERS

Vertex Analysts Lower Their Forecasts Following Q2 Results

Benzinga Earnings

Vertex Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $605 from $600

THOMSON REUTERS

Press Release: Vertex Expands Leadership Team to Power the Next Chapter of Growth

Amgen Declares Q3 2026 Dividend of R$ 0.31 Per Unit

Stocks to Watch: Palantir, SpaceX, HSBC

From Products to Innovation: Three Emerging Sectors Anchor China's Economic Growth in 2025

Vertex Pharmaceuticals Inc : TD Cowen Raises Target Price to $550 from $525

THOMSON REUTERS

Analysts’ Top Technology Picks: Vertex (VERX), Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX)

Vertex Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Amgen Inc. Stock Underperforms Monday When Compared to Competitors

Stoke Therapeutics Q2 Revenue Falls 33% on Lower Collaboration, Licensing Income

Vertex Q2 FY26 GAAP Net Income Rises 6% to $1.1 Billion; Revenue Increases 12% to $3.33 Billion

Vertex Raises Annual Revenue Forecast on Cystic Fibrosis Drugs Strength

Vertex Pharmaceuticals: Guidance Continues to Include Immaterial Cost Impact from Tariffs in 2026 Based on Currently Known Tariff Rates & Regulations

THOMSON REUTERS

Vertex Pharmaceuticals Q2 EPS USD 4.31

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PBE/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":98.7315,"timestamp":1787688000000,"preClose":97.301,"halted":0,"volume":6544,"hourTrading":{"tag":"盘前","latestPrice":98.7195,"preClose":98.7315,"latestTime":"07:02 EDT","volume":4,"amount":394.9227,"timestamp":1787742166498,"change":-0.012,"changeRate":-0.000122,"amplitude":0.000196},"delay":0,"changeRate":0.014701801625882518,"floatShares":4120000,"shares":4120000,"eps":1.793292,"marketStatus":"Pre-Mkt","change":1.4305,"latestTime":"08-26 07:40:24 EDT","open":97.68,"high":98.82,"low":97.68,"amount":644330.0273600001,"amplitude":0.011716,"askPrice":156.98,"askSize":100,"bidPrice":87.42,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":98.7315,"sharesOutstanding":3180000,"nav":97.25464,"aum":401661663.2,"dividendRate":0.01567,"bidAskSpread":0.002967,"preHourTrading":{"tag":"盘前","latestPrice":98.7195,"preClose":98.7315,"latestTime":"07:02 EDT","volume":4,"amount":394.9227,"timestamp":1787742166498,"change":-0.012,"changeRate":-0.000122,"amplitude":0.000196},"postHourTrading":{"tag":"盘后","latestPrice":98.685,"preClose":98.7315,"latestTime":"19:30 EDT","volume":11,"amount":1086.1635,"timestamp":1787700601847,"change":-0.0465,"changeRate":-0.000471,"amplitude":0},"volumeRatio":0.28184543281111296,"impliedVol":0.1495,"impliedVolPercentile":0.076},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4120000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.28184543281111296,"shares":4120000,"dividePrice":1.5471,"high":98.82,"amplitude":0.011716,"preClose":97.301,"low":97.68,"week52Low":67.56,"pbRate":"1.64","psRate":"236.96","week52High":98.82,"institutionHeld":0.2552,"latestPrice":98.7315,"eps":1.793292,"divideRate":0.01567,"volume":6544,"delay":0,"ttmEps":1.793292,"open":97.68,"prevYearClose":82.15,"prevWeekClose":97.59,"prevMonthClose":89.6108,"prevQuarterClose":89.6486,"fiveDayClose":95.28,"twentyDayClose":91.7375,"sixtyDayClose":83.8038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657568150","title":"Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568150?lang=en_us&edition=fundamental","pubTime":"2026-08-05 01:05","pubTimestamp":1785863115,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  remains well positioned heading into the second half of 2026 as several pipeline catalysts approach, while upcoming competitor cystic fibrosis data is unlikely to materially affect its outlook, UBS Securities said in a note Tuesday.The investment firm said expectations around the competitive threat have already moderated, noting Vertex's once-daily Alyftrek has shown strong efficacy and that the rival study's narrower patient population may limit its read-through to Vertex.UBS said it remains most optimistic about phase III data for inaxaplin in APOL1-mediated kidney disease expected in early 2027, saying positive results could position Vertex as the first company to market in the indication and further expand its nephrology franchise.It also highlighted Phase II data expected this fall in APOL1-mediated kidney disease patients with Type 2 diabetes or moderate proteinuria, a population that could expand the drug's addressable market by 50% to 100%.UBS has a buy ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIB","LU0417517546.SGD","BK4533","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2236285917.USD","VERX","LU0256863811.USD","LU0234570918.USD","BK4567","SG9999001176.SGD","BK4139","LU1674673691.USD","LU2362540622.SGD","LU1093756168.USD","LU2237438978.USD","LU0432979614.USD","LU0823416689.USD","LU1093756325.SGD","SGXZ57979304.SGD","LU2468319806.SGD","LU1815336091.USD","TBXU","LU1778281490.HKD","LU2456880835.USD","LU0889565916.HKD","IDNA","PBE","GNMX","BK4532","IBBQ","IBB","LU0320765992.SGD","LU1674673428.USD","IE00B2B36J28.USD","LU1430594728.SGD","VRTX","IE00B19Z9Z06.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","LU0566484027.USD","LU0061475181.USD","LU1035775433.USD","BK4585","BBH","LU1585245621.USD","BK4588","LU2362541513.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657343568","title":"Amgen Extends Obesity Trial, Sharpening Its Long-Term Weight-Loss Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=2657343568","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657343568?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:30","pubTimestamp":1785861046,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The Phase 3 MARITIME-1-EXTENSION study from Amgen Inc. looks at how well and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-extends-obesity-trial-sharpening-its-long-term-weight-loss-bet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-extends-obesity-trial-sharpening-its-long-term-weight-loss-bet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","LU1571399168.USD","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4534","LU2112291526.USD","BK4588","LU0122379950.USD","LU2089984988.USD","PBE","BBH","PJP","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1057294990.SGD","LU0889565916.HKD","BK4599","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","BIB","TBXU","LU1061106388.HKD","IE0009355771.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU2242646821.SGD","AMGN","LU0320765992.SGD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657255048","title":"Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657255048","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657255048?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:02","pubTimestamp":1785859337,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  reported a solid Q2 and raised its outlook, highlighting the strength of its core business and pipeline, RBC Capital Markets said in a note emailed Tuesday.The analysts said the stock could benefit once the Sionna Therapeutics  data overhang clears, with upcoming catalysts including the launch of new products, the expected closing of the Crinetics Pharmaceuticals  deal, and additional pipeline readouts.The stock does not fully reflect the potential upside from pipeline opportunities, including kidney programs, expansion of povetacicept into autoimmune diseases such as IgA nephropathy and generalized myasthenia gravis, and the longer-term potential of suzetrigine in chronic pain, the analysts added.\"We believe that given Vertex's strong core revenue, a pipeline that is increasingly becoming more mature, and with optionality to further diversify pipeline with external [business development,] shares should command a higher valuation,\" the analysts said.RBC lowered ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIB","LU0417517546.SGD","BK4533","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2236285917.USD","VERX","LU0256863811.USD","LU0234570918.USD","BK4567","BK4139","LU1674673691.USD","LU2362540622.SGD","LU2237438978.USD","LU0432979614.USD","LU0823416689.USD","LU1093756325.SGD","SGXZ57979304.SGD","LU2468319806.SGD","LU1815336091.USD","TBXU","LU1778281490.HKD","LU2456880835.USD","LU0889565916.HKD","SION","IDNA","PBE","GNMX","BK4532","IBBQ","IBB","LU0320765992.SGD","LU1674673428.USD","IE00B2B36J28.USD","LU1430594728.SGD","VRTX","IE00B19Z9Z06.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","LU0566484027.USD","LU0061475181.USD","LU1035775433.USD","BK4585","CRNX","BBH","LU1585245621.USD","BK4588","LU2362541513.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656571065","title":"Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656571065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656571065?lang=en_us&edition=fundamental","pubTime":"2026-08-04 23:00","pubTimestamp":1785855621,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and V...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-fresenius-medical-care-fms-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-fresenius-medical-care-fms-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","IDNA","IE00B19Z9Z06.USD","IBB","VRTX","SG9999001176.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2236285917.USD","LU1674673428.USD","LU1035775433.USD","LU2362541273.HKD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU1815336091.USD","TBXU","BBH","LABU","IE00B19Z9P08.USD","LU1430594728.SGD","BK4581","LU2362540622.SGD","BIB","IE0002141913.USD","LU1069344957.HKD","LU2362541513.USD","XBI","AMN","IBBQ","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU2456880835.USD","IE00B894F039.SGD","LU1559883803.SGD","LU1674673691.USD","LU0320765992.SGD","VERX","LU0757428866.USD","GNMX","LU0109394709.USD","PBE","IE0009355771.USD","BK4139","IE00B19Z3B42.SGD","IE00BZ9MQY76.HKD","FMS","LU2324357040.USD","BK4533","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656540305","title":"Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485","url":"https://stock-news.laohu8.com/highlight/detail?id=2656540305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656540305?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:18","pubTimestamp":1785853138,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nAZN4TBOJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","BK4585","ALNY","LU0889565916.HKD","PBE","LU0882574055.USD","GNMX","LU0114720955.EUR","BK4588","LU0320765992.SGD","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656590955","title":"Vertex Analysts Lower Their Forecasts Following Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2656590955","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656590955?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:15","pubTimestamp":1785849333,"startTime":"0","endTime":"0","summary":"Vertex Inc (NASDAQ:VERX) reported strong Q2 earnings, exceeding analyst estimates. Sales for Q3 also expected to beat market estimates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/60906332/vertex-analysts-lower-their-forecasts-following-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0432979614.USD","BIB","GNMX","LU0079474960.USD","IDNA","BK4139","IBB","LU0109394709.USD","LU1674673428.USD","IE00B19Z3581.USD","LU1430594728.SGD","BK4533","SGXZ57979304.SGD","LU1815336091.USD","VERX","IE00BFTCPJ56.SGD","LU2324357040.USD","LU2362541273.HKD","LU0757428866.USD","LU0889565916.HKD","IE00B894F039.SGD","LU1093756168.USD","LU1674673691.USD","LU0234570918.USD","BBH","SG9999001176.USD","VRTX","LU2362541513.USD","LU0566484027.USD","LU2236285917.USD","BK4585","IE0002141913.USD","BK4588","IE00BJT1NW94.SGD","LU2456880835.USD","SG9999001176.SGD","LU2237438978.USD","LU0289739699.SGD","IE0002270589.USD","TBXU","PBE","LU0256863811.USD","IE00BZ9MQY76.HKD","BK4567","IE00B19Z9P08.USD","IBBQ","LU2468319806.SGD","IE00B19Z9Z06.USD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656555785","title":"Vertex Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $605 from $600","url":"https://stock-news.laohu8.com/highlight/detail?id=2656555785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656555785?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:18","pubTimestamp":1785845902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44116O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIB","IBBQ","IE0009355771.USD","LU1093756168.USD","IE0002270589.USD","LU2362540622.SGD","TBXU","BK4533","LU1035775433.USD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","BK4567","IE0002141913.USD","LU0061475181.USD","LU0889565916.HKD","LU1069344957.HKD","BBH","IE00B19Z9P08.USD","LU1674673428.USD","LU2417539215.USD","SGXZ57979304.SGD","GNMX","SG9999013999.USD","IE00B2B36J28.USD","IDNA","BK4139","LU2237438978.USD","LU1093756325.SGD","LU0432979614.USD","LU2089984988.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU0320765992.SGD","LU2468319806.SGD","BK4532","LU2462157665.USD","LU0058720904.USD","PBE","IBB","LU0256863811.USD","LU0079474960.USD","LU0234570918.USD","LU2456880835.USD","VRTX","LU1430594728.SGD","SG9999001176.USD","LU1778281490.HKD","LU1674673691.USD","IE00BFTCPJ56.SGD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656896555","title":"Press Release: Vertex Expands Leadership Team to Power the Next Chapter of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2656896555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656896555?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:00","pubTimestamp":1785844800,"startTime":"0","endTime":"0","summary":"KING OF PRUSSIA, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ: VERX), the Decision-to-Defense(TM) global indirect tax and compliance company, today announced three additions to its leade","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU2468319806.SGD","TM","GNMX","TBXU","PW","BK4234","VRTX","BK4023","03160","IBB","LU0566484027.USD","PBE","SG9999001176.USD","LU0417517546.SGD","LU1674673428.USD","BK4532","LU2456880835.USD","LU0109394709.USD","IE00B2B36J28.USD","SG9999001176.SGD","LU1815336091.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","IDNA","LU1093756325.SGD","LU1559883803.SGD","SGXZ57979304.SGD","IBBQ","LU0432979614.USD","VERX","LU1430594728.SGD","LU0079474960.USD","LU1585245621.USD","TISI","BK4533","BBH","LU0823416689.USD","LU1778281490.HKD","LU2362541513.USD","SG9999013999.USD","LU2362540622.SGD","BK4084","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","LU1674673691.USD","IE00B19Z9P08.USD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553204","title":"Amgen Declares Q3 2026 Dividend of R$ 0.31 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553204","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553204?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:57","pubTimestamp":1785844643,"startTime":"0","endTime":"0","summary":"Amgen declares Q3 2026 dividend of R$ 0.31 per unitAmgen declared a 3Q 2026 cash distribution of R$ 0.31 per unit .Shares trade with entitlement through Aug. 19.Payment is scheduled for Sept. 17.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL21yKFh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","BK4585","TBXU","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","LU1061106388.HKD","BK4588","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK4533","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656755539","title":"Stocks to Watch: Palantir, SpaceX, HSBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2656755539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656755539?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:21","pubTimestamp":1785835260,"startTime":"0","endTime":"0","summary":"Palantir Technologies : Shares in the software company jumped over 15% premarket after it reported strong earnings yesterday after the close.BP : The energy company posted surging profits driven by strong oil trading performance and higher prices. Shares ticked up slightly following the report.HSBC : The British bank reported higher quarterly profit and announced a $1 billion share buyback, but its size disappointed some investors; shares ticked down.Prologis , Segro  : Warehouse landlord Prologis agreed to buy its British rival for $18.8 billion. Segro shares inched up while Prologis stock was little changed premarket.Toyota Motor : The Japanese automaker posted a 76% surge in quarterly profit and raised its full-year earnings forecast, but the stock slipped in Japan.Space Exploration Technologies : Elon Musk's rocket and AI company is set to deliver its first-ever earnings report as a public company after markets close.Pfizer , Merck , Amgen , BioNTech : The pharmaceutical companies ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154778.USD","LU2468319806.SGD","IE0009355771.USD","LU0889566641.SGD","LU1037948897.HKD","LU2242646821.SGD","LU0170899867.USD","SOXY","LU1732799900.SGD","LU1162221912.USD","BK4605","SPCM","LU0823416689.USD","SGXZ99366536.SGD","BK4504","IE00BZ9MQY76.HKD","PSR","ARTY","AMDL","LU2023250504.SGD","LU2023250843.SGD","LU0306806265.USD","SPAX","HRTS","LU1852331112.SGD","LU2491050071.SGD","LU1066053197.SGD","SG9999014542.SGD","BK4567","IE00BQXX3F31.USD","LU0289739699.SGD","LU1983260115.SGD","BK4575","IE00BQXX3C00.GBP","SG9999011175.SGD","AMDG","PLTY","LU2362541273.HKD","BK4547","LU1303367103.USD","DTRE","LU1061106388.HKD","LU1929549753.HKD","AIQ","LU2360107168.USD","WARP","PLTD","IE0002141913.USD","BK4550","BK4533","HSBH","WUGI","LU0128525689.USD","LU2106854487.HKD","SG9999001176.USD","TRUH","TEK","BIB","PLYY","DFAR","SPCH","LU0133085943.USD","LU0198837287.USD","LU0792757196.USD","LU1093756325.SGD","PLT","LU1934455277.USD","CRED","LU0251132253.USD","PAWZ","LU1861220033.SGD","LU0823421333.USD","SOXX","LU1291159041.SGD","LU2361044949.HKD","PPTY","LU1074936037.SGD","DPRE","IE00B19Z9Z06.USD","CLIM","00005","IE0009356076.USD","LU1880398554.USD","SG9999014567.USD","SPCX","VNQ","BBH","LU0052756011.USD","IE00BMPRXQ63.HKD","LU0130102774.USD","LU0889565833.HKD","BK4559","LU1989772923.USD","BMED","LU2361045086.USD","IE00BJT1NW94.SGD","IE00BJJMRY28.SGD","LU1232071149.USD","HSBC","BK4581","IE0004445239.USD","BK4592","LU2362540622.SGD","LU2360106780.USD","LU1883839398.USD","IE00BJJMRZ35.SGD","LEGR","AMDS","SHLD","LU2089985449.USD","IE00BLSP4239.USD","SPCQ","LU0098860793.USD","IE00BQXX3D17.EUR","SG9999001176.SGD","JRE","URE","LU2458330243.SGD","LU1989764748.USD","USXF","AIS","RWR","FRI","BK4207","LU1267930813.SGD","WSPC","LU1316542783.SGD","XLV","AVRE","PLOO","IHE","LU1989772840.SGD","LU2347655073.USD","LU1861215975.USD","AMUU","BK4551","IBB","LU1267930227.SGD","SPOG","REET","JPRE","LU1037948541.HKD","LU1035773651.USD","LU2324357040.USD","IYRI","VGSR","PBE","PTIR","IE00B3T34201.USD","IE00BBT3K403.USD","LU0726765562.USD","LU1718418525.SGD","LU0056508442.USD","LU0985481810.HKD","LU0208291251.USD","LU0965509101.SGD","LU1242518857.USD","BK4566","AMGN","IE00BFSS7M15.SGD","IE00BSNM7G36.USD","LU0985320562.USD","RNTY","TM","LU2347655156.SGD","LU0823421416.USD","IE00BLSP4452.SGD","SG9999003800.SGD","SG9999001440.SGD","LU1861559042.SGD","BK4588","MARS","EYES","BK4532","BK4568","LU0795875169.SGD","LU1923622614.USD","BK4209","LU2362541513.USD","LU0306807586.USD","SPCF","LU0965509010.AUD","BK4610","LU1983299246.USD","TTEQ","ORBX","IE00B19Z3B42.SGD","SG9999002224.SGD","WISE","SG9999013999.USD","BK4534","BK4571","LU1066051811.HKD","LU0225771236.USD","PLTG","BK4573","LU0965509283.SGD","TBXU","IXJ","AMDY","LU0648001328.SGD","LU1093756168.USD","LU0321505868.SGD","LU0265550946.USD","LU0127658192.USD","RITA","BK4554","LU1571399168.USD","LU1934455863.HKD","AMYY","ILDR","LU0889565916.HKD","WTRE","BNTX","AMDW","BK4007","PFE","USRT","LU2247934214.USD","SGXZ81514606.USD","LU0976567544.SGD","LU1803068979.SGD","PLTU","LU1934455194.USD","JDOC","IE0004445015.USD","LU1989764664.SGD","AIPI","LU0124676726.USD","LU0823434740.USD","LU2236285917.USD","BAI","SSPC","LU2242652126.USD","LU1988902786.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","BK4023","LU0266013472.USD","SG9999001424.SGD","LU2125154935.USD","LU1941712348.USD","REIT","PPH","OZEM","IE00B4R5TH58.HKD","LU0689626769.HKD","LU1894683348.USD","SG9999014575.USD","LU0070302665.USD","LU2357627491.SGD","SG9999002232.USD","LU0456855351.SGD","LU2265009873.SGD","FHLC","GDOC","BK4604","LU2264538146.SGD","LU1880398471.USD","XLRE","LU1923623000.USD","LU1894683264.USD","SPOT","AMDD","LU2458330169.SGD","LU1069347547.HKD","PJP","FAI","LU2098885051.SGD","LU2433249047.HKD","LU0320765489.SGD","LU0006306889.USD","LU1941712264.USD","IE00BZ1G4Q59.USD","FREL","LU1917777945.USD","LU0965508806.USD","LU2491050154.USD","ICF","LU2461242641.AUD","AMDU","LU0786609619.USD","BK4224","BK4139","PLTZ","LU0203347892.USD","BK4108","04332","RWO","BK4614","QQQA","IGV","IE00B7KXQ091.USD","BK4171","LU0861579265.USD","SMHX","BK4516","IBBQ","IE000M9KFDE8.USD","LU1057294990.SGD","PLD","LU2250418816.HKD","BK4529","VHT","BK4548","INDS","DFGR","LU0320765646.SGD","BK4089","SG9999015358.SGD","LU2361044865.SGD","BK4612","GAMR","LU1066051225.USD","BK4141","BK4512","LU0211326755.USD","TRUR","LU1951198990.SGD","LU1699723380.USD","LU0211326839.USD","LU0130517989.USD","LU1804176565.USD","LU0081259029.USD","LU0496365809.HKD","LU0321505439.SGD","BK4613","IE0002270589.USD","RXL","LU2896262040.SGD","LU0417517546.SGD","LU2125909247.SGD","LOFF","IE00BFSS8Q28.SGD","LU2242649171.HKD","IYH","LU0942090050.USD","LU1116320737.USD","LU1116320901.HKD","LU0274383776.USD","LU0234572021.USD","LU2355687059.USD","LU0174119429.USD","LU0979878070.USD","SPCG","LU2360032135.SGD","GUNZ","LU1861558580.USD","IE00BJTD4V19.USD","LU0642271901.SGD","MRK","LU2290526834.HKD","IE00B2B36J28.USD","BK4599","LU1732800096.USD","LU0868494708.USD","LU0211331839.USD","SCHH","PSI","FTXH","LU2596442595.SGD","LU0210536198.USD","03160","PLTI","IE00BJTD4N35.SGD","IE00BN8TJ469.HKD","LU1430594728.SGD","LU2860962120.EUR","LU1244550577.SGD","ERET","IE00BMPRXR70.SGD","LU2491049909.HKD","LU1066051498.USD","LU0310800965.SGD","BK4535","BK4099","BK4543","LU0719512351.SGD","LU2108987350.USD","LU1242518931.SGD","MCD","LU0477156953.USD","LU0082616367.USD","LU0122379950.USD","TRFK","LU0048584097.USD","LU2125909593.SGD","SMH","IE00BMPRXN33.USD","CHAT","IE00B19Z9P08.USD","IE00B1BXHZ80.USD","LU0823434583.USD","LU1064131342.USD","BBRE","CHPS","LU2931357623.SGD","DAMD","LU2112291526.USD","FTXL","LU0795875086.SGD","LU1244550221.USD","AMD","LU2054465674.USD","IE00BKVL7J92.USD","LU1023059063.AUD","PLTR","LU1244550494.USD","LU0106261372.USD","LU1201861249.SGD","LU0203345920.USD","IE00BJJMRX11.SGD","PLTA","IYR","LU0912757837.SGD","SGXZ57979304.SGD","LU0225284248.USD","BK4521","LU2462591350.SGD","LU1951200564.SGD","LU0320765992.SGD","LU0109394709.USD","SG9999014559.SGD","LU0859254822.USD","BK4555","LU2279689827.SGD","LU0058720904.USD","LU0868494617.USD","SG9999015341.SGD","IETC","LU1974910355.USD","SGXZ51526630.SGD","LU0256863811.USD","LU0980610538.SGD","LU1585245621.USD","XNTK","SPRE","IE00B894F039.SGD","BK4585","IE00B5949003.HKD","PLTW","LU2133065610.SGD","LU0432979614.USD","LU0265550359.USD","IE00B19Z3581.USD","LU0109392836.USD","LU0390134368.USD","LU2089984988.USD","LU1989771016.USD","IE0001KFT4U8.USD","CNAV","GQRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102575318","title":"From Products to Innovation: Three Emerging Sectors Anchor China's Economic Growth in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1102575318","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102575318?lang=en_us&edition=fundamental","pubTime":"2026-08-04 16:03","pubTimestamp":1785830609,"startTime":"0","endTime":"0","summary":"As the first half of 2025 concludes, marking the initial phase of the 15th Five-Year Plan, new development opportunities and emerging growth drivers are solidifying China's economic foundation....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","601869","06869","BK4585","BK4139","IMAB","BK4535","BK4526","BK0214","BIIB","BK4588","LU0320765992.SGD","PBE","BK4532","LU0889565916.HKD","IE00B19Z9Z06.USD","LU0109394709.USD","BK4533","IE00B19Z9P08.USD","BK4505","LU0234570918.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656581656","title":"Vertex Pharmaceuticals Inc : TD Cowen Raises Target Price to $550 from $525","url":"https://stock-news.laohu8.com/highlight/detail?id=2656581656","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656581656?lang=en_us&edition=fundamental","pubTime":"2026-08-04 11:55","pubTimestamp":1785815744,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1778281490.HKD","IE00B4R5TH58.HKD","BBH","GNMX","IE0002270589.USD","IE00B19Z3581.USD","PBE","LU1674673428.USD","LU2237438978.USD","IE00BJJMRZ35.SGD","IBBQ","LU0109394709.USD","IE00B19Z3B42.SGD","LU2362541513.USD","LU2417539215.USD","LU2468319806.SGD","VRTX","LU2456880835.USD","LU1585245621.USD","IE00BZ9MQY76.HKD","LU0889565916.HKD","LU0079474960.USD","SG9999001176.SGD","LU1430594728.SGD","BK4588","LU0823416689.USD","IE0002141913.USD","IDNA","LU2362541273.HKD","LU0256863811.USD","BK4532","LU0417517546.SGD","LU2236285917.USD","LU0058720904.USD","TBXU","IE0009355771.USD","LU2089984988.USD","LU0289739699.SGD","IBB","BIB","LU2324357040.USD","LU0234570918.USD","IE00B894F039.SGD","LU1093756325.SGD","LU0061475181.USD","BK4567","IE00B19Z9Z06.USD","LU1093756168.USD","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656583212","title":"Analysts’ Top Technology Picks: Vertex (VERX), Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656583212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656583212?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:30","pubTimestamp":1785803405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Vertex (VERX) and Life360 Shs Chess Depository Inter...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-technology-picks-vertex-verx-life360-shs-chess-depository-interests-repr-3-sh-lifx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-technology-picks-vertex-verx-life360-shs-chess-depository-interests-repr-3-sh-lifx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTY","TECS","LU2362541513.USD","IE00B2B36J28.USD","SG9999001176.USD","LU2362540622.SGD","VERX","IE00BFTCPJ56.SGD","PBE","LU1674673691.USD","LU2462157665.USD","LU0109394709.USD","IE0002270589.USD","BBH","BK4567","VRTX","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2362541273.HKD","SGXZ57979304.SGD","LU0320765992.SGD","GNMX","LU0234570918.USD","BIB","IE00B4R5TH58.HKD","LU1815336091.USD","LU1559883803.SGD","LIFX","BK4588","IE00B19Z3B42.SGD","LU0889565916.HKD","IE00B894F039.SGD","IE00B19Z3581.USD","SG9999001176.SGD","LU2324357040.USD","IBB","IBBQ","IE00BJT1NW94.SGD","BK4023","LU2417539215.USD","LIF","LU0061475181.USD","IE00B19Z9Z06.USD","LU0079474960.USD","LU1430594728.SGD","LU0823416689.USD","IDNA","LU1093756168.USD","LU0417517546.SGD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656423302","title":"Vertex Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656423302","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656423302?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:01","pubTimestamp":1785790899,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryVertex Pharmaceuticals IncVRTX.OQreported quarterly adjusted earnings of $4.73 per share for the quarter ende","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4402FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","LU2462157665.USD","BK4585","BBH","GNMX","IE0002270589.USD","IE00B19Z3581.USD","PBE","LU1674673428.USD","IE00BJJMRZ35.SGD","IBBQ","LU0109394709.USD","IE00B19Z3B42.SGD","LU2362541513.USD","LU2417539215.USD","LU2468319806.SGD","VRTX","LU2456880835.USD","LU1585245621.USD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","LU1674673691.USD","LU1069344957.HKD","SG9999001176.SGD","BK4588","LU0823416689.USD","IE0002141913.USD","IDNA","LU2362541273.HKD","BK4532","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU2236285917.USD","TBXU","IE0009355771.USD","LU0289739699.SGD","IBB","IE00B19Z9P08.USD","LU0320765992.SGD","BK4533","BIB","LU2324357040.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","BK4567","LU2362540622.SGD","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656047703","title":"Amgen Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2656047703","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656047703?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:34","pubTimestamp":1785789240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.63% to $378.87 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.48% to 7,600.50 and the Dow Jones Industrial Average  rising 1.32% to 53,178.41.This was the stock's second consecutive day of losses.Amgen Inc. closed 4.81% below its 52-week high of $398.00, which the company achieved on July 28th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.76% to $254.41, Pfizer Inc.  rose 0.08% to $25.03, and AbbVie Inc.  fell 2.33% to $245.10.Data source: Dow Jones Market Data, FactSet. Data compiled August 3, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0058720904.USD","IBB","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0122379950.USD","BK4588","IE00B4R5TH58.HKD","PJP","IE00BJJMRZ35.SGD","LU2242652126.USD","TBXU","SG9999001440.SGD","BBH","LU1061106388.HKD","AMGN","LU1571399168.USD","BK4581","BK4566","LU1057294990.SGD","BIB","IE0002141913.USD","04332","LU0289739699.SGD","IBBQ","BK4599","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0320765992.SGD","LU2242646821.SGD","LU2468319806.SGD","LU2112291526.USD","LU0109394709.USD","PBE","BK4534","LU1983299246.USD","IE0009355771.USD","BK4139","LU0868494617.USD","BK4533","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656301488","title":"Stoke Therapeutics Q2 Revenue Falls 33% on Lower Collaboration, Licensing Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2656301488","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656301488?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:11","pubTimestamp":1785787868,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics Q2 revenue falls 33% on lower collaboration, licensing incomeOverviewUS biotechnology firm's Q2 revenue fell but beat analyst expectationsNet loss widened yr/yr, reflecting higher R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N4400YP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","TGTX","IE00B894F039.SGD","BK4007","BK4588","PBE","LU0109394709.USD","BK4139","BK4585","IE00B19Z9P08.USD","BK4533","BMED","BIIB","STOK","LU0320765992.SGD","BK4532","OCUL","IE00B19Z9Z06.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656330905","title":"Vertex Q2 FY26 GAAP Net Income Rises 6% to $1.1 Billion; Revenue Increases 12% to $3.33 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2656330905","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656330905?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:03","pubTimestamp":1785787395,"startTime":"0","endTime":"0","summary":"Vertex Q2 FY26 GAAP net income rises 6% to $1.1 billion; revenue increases 12% to $3.33 billionVertex Q2 2026 revenue rose 12% to $3.33 billion from a year earlier; GAAP net income climbed to $1.1 bil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLbsbckn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","LU2462157665.USD","IE00B4R5TH58.HKD","BBH","GNMX","IE0002270589.USD","IE00B19Z3581.USD","LU1035775433.USD","PBE","LU1674673428.USD","LU2237438978.USD","IE00BJJMRZ35.SGD","IBBQ","LU0109394709.USD","IE00B19Z3B42.SGD","LU2362541513.USD","LU2417539215.USD","LU2468319806.SGD","SG9999001176.USD","VRTX","LU1585245621.USD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","LU0889565916.HKD","LU1674673691.USD","SG9999001176.SGD","LU0432979614.USD","LU1430594728.SGD","BK4588","LU0823416689.USD","IE0002141913.USD","IDNA","LU0417517546.SGD","LU2236285917.USD","TBXU","IE0009355771.USD","LU2089984988.USD","SG9999013999.USD","LU0289739699.SGD","IBB","BK4533","BIB","LU0234570918.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","BK4567","IE00B19Z9Z06.USD","LU1093756168.USD","LU2362540622.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656097243","title":"Vertex Raises Annual Revenue Forecast on Cystic Fibrosis Drugs Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2656097243","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656097243?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:02","pubTimestamp":1785787357,"startTime":"0","endTime":"0","summary":"Vertex raises annual revenue forecast on cystic fibrosis drugs strengthAug 3 (Reuters)-Vertex PharmaceuticalsVRTX.Oon Monday raised theupper endof its annual revenue forecast, banking on robust demand","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4N4401S2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","BK4139","IDNA","IE00B19Z9P08.USD","LU1585245621.USD","IBB","LU0061475181.USD","LU2236285917.USD","LU0256863811.USD","LU1674673428.USD","LU1430594728.SGD","PBE","LU0823416689.USD","IE0002270589.USD","LU0432979614.USD","SG9999001176.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","CRNX","BK4567","VRTX","BK4007","IE00B894F039.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1674673691.USD","LU2362540622.SGD","SGXZ57979304.SGD","LU2468319806.SGD","LU1778281490.HKD","LU2417539215.USD","IE00B19Z3581.USD","BK4585","IBBQ","LU1093756168.USD","BBH","LU2456880835.USD","SG9999013999.USD","IE0009355771.USD","LU1035775433.USD","TBXU","LU1069344957.HKD","IE00BFTCPJ56.SGD","LU2362541273.HKD","SG9999001176.SGD","BIB","IE00B2B36J28.USD","BK4532","LU1093756325.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656704309","title":"Vertex Pharmaceuticals: Guidance Continues to Include Immaterial Cost Impact from Tariffs in 2026 Based on Currently Known Tariff Rates & Regulations","url":"https://stock-news.laohu8.com/highlight/detail?id=2656704309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656704309?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787264,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLX5FPH53:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0079474960.USD","IBB","LU0234570918.USD","IDNA","BIB","IE00BJT1NW94.SGD","LU2462157665.USD","LU1430594728.SGD","LU1674673428.USD","BK4585","IE00B4R5TH58.HKD","SG9999001176.SGD","IE0009355771.USD","IE00B19Z3B42.SGD","BBH","LU0058720904.USD","LU0432979614.USD","LU2324357040.USD","LU2362541273.HKD","LU2456880835.USD","SG9999013999.USD","LU2468319806.SGD","IE00B894F039.SGD","PBE","IE0002270589.USD","LU0061475181.USD","LU0417517546.SGD","LU0109394709.USD","IE00B19Z9P08.USD","VRTX","IE00BJJMRZ35.SGD","LU1093756325.SGD","SGXZ57979304.SGD","BK4532","GNMX","IE00B2B36J28.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","IE0002141913.USD","LU2237438978.USD","IE00B19Z9Z06.USD","IBBQ","LU2089984988.USD","LU1093756168.USD","LU0320765992.SGD","TBXU","BK4139","LU2362540622.SGD","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656249309","title":"Vertex Pharmaceuticals Q2 EPS USD 4.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2656249309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656249309?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787264,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLX5FPH53:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1778281490.HKD","LU1430594728.SGD","GNMX","IE0009355771.USD","LU1585245621.USD","LU2417539215.USD","LU2456880835.USD","BIB","IBB","LU2462157665.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU1674673691.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU2236285917.USD","BK4533","LU1674673428.USD","LU0320765992.SGD","IBBQ","SG9999001176.SGD","BK4585","BK4588","IE00B19Z9Z06.USD","BK4567","LU2362540622.SGD","LU2362541273.HKD","LU2468319806.SGD","SGXZ57979304.SGD","IE0002270589.USD","IE0002141913.USD","LU1069344957.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IDNA","PBE","SG9999001176.USD","LU0058720904.USD","BBH","LU0256863811.USD","IE00B19Z9P08.USD","LU0234570918.USD","LU2237438978.USD","VRTX","LU0432979614.USD","IE00B894F039.SGD","TBXU","LU1035775433.USD","LU2362541513.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}